新产品
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 2091906 | BAY-2416964 | 2242464-44-2 | 98% Min. |  |
| BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist | ||||
| 20103001 | ASN007 | 2055597-12-9 | ≧98.0% |  |
| ASN007 , a novel oral ERK inhibitor , has shown anti-tumor activity in both solid tum | ||||
| 20103002 | Senaparib | 1401682-78-7 | ≧98.0% |  |
| Senaparib (IMP4297) is a novel agent targeting PARP (poly-ADP ribose polymerase) with | ||||
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||
| 20123101 | Samelisant | 1415792-84-5 | ≧98.0% |  |
| Samelisantis a novel, highly selective and potent small molecule oral inhibitor targe | ||||
| 26188 | Firibastat ( QGC-001 ) | 648927-86-0 | ≧98.0% |  |
| Firibastat, (originally named QGC001) is the first drug candidate of a new class of c | ||||
| 21236 | Centanafadine HCl | 923981-14-0 | ≧98.0% |  |
| Centanafadine, also known as EB-1020, is an adrenergic uptake inhibitor and dopamine | ||||
| 210507 | LP-261 | 915412-67-8 | ≧98.0% |  |
| LP-261 is a novel tubulin targeting anticancer agent that binds at the colchicine sit | ||||
| 21248 | Giredestrant | 1953133-47-5 | ≧98.0% |  |
| Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally ava | ||||
| 21252 | SM-102 | 2089251-47-6 | ≧98.0% |  |
| SM-102 is an ionizable amino lipid that has been used in combination with other lipid | ||||
| 16122809 | 依拉司群 | 722533-56-4 | ≧98.0% |  |
| 依拉司群(Elacestrant), also known as RAD1901, is an orally available, selective e | ||||
| 20263 | Giredestrant tartrate | 2407529-33-1 | ≧98.0% |  |
| Giredestrant tartrate (GDC-9545 tartrate), a non-steroidal ER ligand, is an orally ac | ||||